Table 1. Baseline clinical characteristics.
*ST group | Non-ST group | P value | |
Variable | (n = 20) | (n = 40) | |
Age (mean), y | 60.3±8.9 | 59.0±7.5 | 0.564 |
Male, n (%) | 17 (85%) | 30 (75%) | 0.384 |
Hypertension, n (%) | 13 (65%) | 18 (45%) | 0.149 |
Diabetes mellitus, n (%) | 9 (45%) | 12 (30%) | 0.132 |
Smoking, n (%) | 11 (55%) | 17 (42.5%) | 0.369 |
High sensitive † CRP (mg/L) | 14.2±18.9 | 18.9±37.1 | 0.597 |
Total cholesterol (mg/dL) | 166.2±37.2 | 183.2±35.2 | 0.089 |
Triglyceride (mg/dL) | 157.1±115.2 | 147.6±60.6 | 0.676 |
Uric acid (mg/dL) | 5.7±1.3 | 6.2±1.7 | 0.243 |
Ejection fraction (%) | 60.9±12.4 | 59.3±11.9 | 0.631 |
ST, stent thrombosis.
CRP, C-reactive protein.
Baseline clinical characteristics of the stent thrombosis and non-stent thrombosis groups.